S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
3rd Massive Dollar Upheaval Has Started (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
3rd Massive Dollar Upheaval Has Started (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
3rd Massive Dollar Upheaval Has Started (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
3rd Massive Dollar Upheaval Has Started (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
3rd Massive Dollar Upheaval Has Started (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
3rd Massive Dollar Upheaval Has Started (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
3rd Massive Dollar Upheaval Has Started (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
3rd Massive Dollar Upheaval Has Started (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
NYSE:BAX

Baxter International - BAX Stock Forecast, Price & News

$58.95
-0.76 (-1.27%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$58.73
$59.82
50-Day Range
$57.91
$74.47
52-Week Range
$57.49
$89.70
Volume
2.51 million shs
Average Volume
3.18 million shs
Market Capitalization
$29.69 billion
P/E Ratio
29.48
Dividend Yield
1.94%
Price Target
$79.29

Baxter International MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
34.5% Upside
$79.29 Price Target
Short Interest
Healthy
1.32% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
-0.03mentions of Baxter International in the last 14 days
Based on 13 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.15%
From $3.62 to $4.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.23 out of 5 stars

Medical Sector

8th out of 1,098 stocks

Surgical & Medical Instruments Industry

1st out of 112 stocks

BAX stock logo

About Baxter International (NYSE:BAX) Stock

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Analyst Ratings Changes

A number of research analysts have commented on the company. The Goldman Sachs Group restated a "sell" rating and issued a $60.00 target price (down previously from $70.00) on shares of Baxter International in a research note on Wednesday, August 3rd. Morgan Stanley decreased their price target on Baxter International from $86.00 to $72.00 and set an "overweight" rating on the stock in a research report on Friday, July 29th. Stifel Nicolaus cut their price target on Baxter International from $85.00 to $75.00 in a research note on Monday, July 18th. Cowen dropped their price objective on Baxter International from $95.00 to $70.00 in a research note on Friday, July 29th. Finally, TheStreet cut Baxter International from a "b-" rating to a "c" rating in a report on Thursday, April 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, Baxter International presently has a consensus rating of "Moderate Buy" and a consensus target price of $79.29.

Baxter International Stock Performance

BAX traded down $0.49 during trading on Tuesday, reaching $59.22. 47,705 shares of the company's stock were exchanged, compared to its average volume of 3,271,772. The stock has a market capitalization of $29.82 billion, a P/E ratio of 29.86, a price-to-earnings-growth ratio of 1.60 and a beta of 0.61. Baxter International has a 1 year low of $57.49 and a 1 year high of $89.70. The company's fifty day simple moving average is $65.87 and its 200-day simple moving average is $74.42. The company has a debt-to-equity ratio of 1.83, a current ratio of 2.01 and a quick ratio of 1.33.

Baxter International (NYSE:BAX - Get Rating) last issued its quarterly earnings data on Thursday, July 28th. The medical instruments supplier reported $0.87 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.87. Baxter International had a net margin of 7.12% and a return on equity of 21.75%. The firm had revenue of $3.75 billion for the quarter, compared to analyst estimates of $3.88 billion. During the same period in the previous year, the firm earned $0.80 EPS. Baxter International's revenue was up 20.9% on a year-over-year basis. As a group, research analysts predict that Baxter International will post 3.62 earnings per share for the current fiscal year.

Baxter International Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 3rd. Shareholders of record on Friday, September 2nd will be paid a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 1.96%. The ex-dividend date is Thursday, September 1st. Baxter International's payout ratio is 58.00%.

Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Stock News Headlines

Baxter Reports Second-Quarter 2022 Results
See More Headlines
Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Company Calendar

Ex-Dividend for 7/1 Dividend
6/02/2022
Dividend Payable
7/01/2022
Last Earnings
7/28/2022
Today
8/09/2022
Ex-Dividend for 10/3 Dividend
9/01/2022
Dividend Payable
10/03/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
60,000
Year Founded
1931

Price Target and Rating

Average Stock Price Forecast
$79.29
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+34.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
13 Analysts

Profitability

Net Income
$1.28 billion
Pretax Margin
7.91%

Debt

Sales & Book Value

Annual Sales
$12.78 billion
Cash Flow
$5.48 per share
Book Value
$18.22 per share

Miscellaneous

Free Float
502,553,000
Market Cap
$29.69 billion
Optionable
Optionable
Beta
0.61

Social Links















BAX Stock - Frequently Asked Questions

Should I buy or sell Baxter International stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 1 sell rating, 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BAX shares.
View BAX analyst ratings
or view top-rated stocks.

What is Baxter International's stock price forecast for 2022?

13 equities research analysts have issued 1-year price objectives for Baxter International's stock. Their BAX share price forecasts range from $60.00 to $100.00. On average, they expect the company's stock price to reach $79.29 in the next year. This suggests a possible upside of 34.5% from the stock's current price.
View analysts price targets for BAX
or view top-rated stocks among Wall Street analysts.

How has Baxter International's stock price performed in 2022?

Baxter International's stock was trading at $85.84 at the beginning of the year. Since then, BAX shares have decreased by 31.3% and is now trading at $58.95.
View the best growth stocks for 2022 here
.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our BAX earnings forecast
.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) released its earnings results on Thursday, July, 28th. The medical instruments supplier reported $0.87 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.87. The medical instruments supplier had revenue of $3.75 billion for the quarter, compared to analyst estimates of $3.88 billion. Baxter International had a trailing twelve-month return on equity of 21.75% and a net margin of 7.12%. Baxter International's revenue was up 20.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.80 EPS.
Read the conference call transcript
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, July 12th. Stockholders of record on Friday, September 2nd will be paid a dividend of $0.29 per share on Monday, October 3rd. This represents a $1.16 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date is Thursday, September 1st.
Read our dividend analysis for BAX
.

Is Baxter International a good dividend stock?

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.94%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 58.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BAX will have a dividend payout ratio of 28.57% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BAX.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International updated its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $3.60-$3.70 for the period, compared to the consensus estimate of $4.13. The company issued revenue guidance of -.

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.30%), Cooke & Bieler LP (0.26%), Pensioenfonds Rail & OV (0.24%), Bartlett & Co. LLC (0.12%), New York State Teachers Retirement System (0.11%) and Mitsubishi UFJ Trust & Banking Corp (0.08%). Insiders that own company stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends
.

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $58.95.

How much money does Baxter International make?

Baxter International (NYSE:BAX) has a market capitalization of $29.69 billion and generates $12.78 billion in revenue each year. The medical instruments supplier earns $1.28 billion in net income (profit) each year or $2.00 on an earnings per share basis.

How many employees does Baxter International have?

Baxter International employs 60,000 workers across the globe.

Does Baxter International have any subsidiaries?

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..
Read More

When was Baxter International founded?

Baxter International was founded in 1931.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.

This page (NYSE:BAX) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.